Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

Thursday’s trading has closed, but IMGN is being traded in the after-hours session. After-Hours quote »
17.90
Delayed Data
As of 3:59pm ET
 +0.04 / +0.22%
Today’s Change
5.34
Today|||52-Week Range
19.43
+193.44%
Year-to-Date

Today’s Trading

Previous close17.86
Today’s open17.84
Day’s range17.32 - 18.11
Volume633,747
Average volume (3 months)1,942,037
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)+4.60%
Earnings growth (this year)+19.60%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+68.55%
P/E ratioNM
Price/Sales16.91
Price/Book20.27

Competitors

 Today’s
change
Today’s
% change
MCRBSeres Therapeutics I...+0.41+1.09%
MNTAMomenta Pharmaceutic...-0.21-0.96%
AXONAxovant Sciences Ltd-0.26-1.75%
RLYPRelypsa Inc-0.34-1.00%
Data as of 4:01pm ET, 07/30/2015

Financials

Next reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$59.9M
Annual profit (last year)-$71.4M
Net profit margin-119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts